Table 1.
Clinical data of IHS > 1.25 group and IHS ≤ 1.25 group
| variable | Total (n = 465) | IHS > 1.25 group (n = 122) | IHS ≤ 1.25 group (n = 343) | P |
|---|---|---|---|---|
| Age | 9.53 ± 1.60 | 8.59 ± 1.41 | 9.79 ± 1.48 | < 0.01 |
| gender | 219/246 | 68/54 | 151/192 | < 0.01 |
| Other allergic diseases (merged/not combined) | 121/344 | 35/87 | 86/257 | 0.423 |
| Allergens (simple/mixed) | 302/163 | 74/48 | 228/115 | 0.221 |
| Family history (with/without) | 138/327 | 35/87 | 103/240 | 0.805 |
| TNSS | ||||
| SNAP-IV | 5.68 ± 2.00 | 7.38 ± 1.69 | 5.04 ± 1.79 | < 0.01 |
| Inattention | 9.70 ± 5.40 | 15.48 ± 4.29 | 7.61 ± 4.01 | < 0.01 |
| Hyperactivity/impulsivity | 8.51 ± 5.03 | 13.91 ± 2.77 | 6.49 ± 3.13 | < 0.01 |
| IHS | 1.01 ± 0.47 | 1.68 ± 0.29 | 0.78 ± 0.39 | < 0.01 |
| PRQLQ | ||||
| Nasal symptom score | 2.46 ± 1.28 | 3.55 ± 1.09 | 2.04 ± 1.21 | < 0.01 |
| Ocular symptoms score | 1.79 ± 0.99 | 2.34 ± 0.96 | 1.67 ± 0.93 | < 0.01 |
| Behavioral problem score | 1.99 ± 0.88 | 2.61 ± 0.81 | 1.77 ± 0.84 | < 0.01 |
| Non-eye and nose symptoms score | 1.34 ± 0.95 | 2.04 ± 0.83 | 1.09 ± 0.84 | < 0.01 |
| Activity and sleep score | 1.25 ± 0.77 | 1.74 ± 0.75 | 1.06 ± 0.73 | < 0.01 |
| AR duration in 1 year | ||||
| ≤ 1 month | 142(30.5) | 11 (8.6) | 131 (38.1) | < 0.01 |
| 1~3 months | 139(29.9) | 22 (18.1) | 117 (34.1) | < 0.01 |
| 3~6 months | 112(24.1) | 57 (46.6) | 55 (16.1) | < 0.01 |
| 6~9 months | 49(10.5) | 24 (19.8) | 25 (7.4) | < 0.01 |
| 9~12 months | 23(4.9) | 8 (6.9) | 15 (4.3) | 0.267 |
| Skin index | ||||
| + | 124(26.7) | 17 (13.8) | 107 (31.3) | < 0.01 |
| ++ | 182(39.1) | 47 (38.8) | 135 (39.3) | 0.948 |
| +++ | 138(29.7) | 48 (39.7) | 90 (26.3) | < 0.01 |
| ++++ | 21(4.5) | 10 (7.8) | 11 (3.1) | 0.031 |
P:comparison between IHS > 1.25 group and IHS ≤ 1.25 group